September 26th 2019 11:00 am EDT | 4pm BST/ 5pm CEST
Emerging leaders in generics: Successful strategies for growth
Discover upcoming global generic product opportunities and strategies for successful growth.
The API and generic dose industries continue to face significant challenges from disruptive forces, such as customer consolidation and increasing competition in local and regulated markets.
Additionally, innovator pipelines are increasingly shifting away from simple small molecule drugs to complex specialty-driven medicines and biologic therapies.
This webinar will present insights into upcoming generic product opportunities around the world and the strategies for successfully unlocking new value over the next 5 years.
Additionally, innovator pipelines are increasingly shifting away from simple small molecule drugs to complex specialty-driven medicines and biologic therapies.
This webinar will present insights into upcoming generic product opportunities around the world and the strategies for successfully unlocking new value over the next 5 years.
We will be covering the following topics:
-
How emerging API and finished dose companies can accelerate their growth and claim leadership positions
-
The competitive landscape in small molecule oral solids, complex and high barrier-to-entry generics and biologics, and hospital injectables
-
Identification of new product opportunities to match best-in-class portfolio strategies
-
The trends in novel drug approvals and implications for future generic pipelines
Featured speaker:
Brandon Boyd
Director of Strategy & Thought Leadership, Life Sciences, Clarivate Analytics
Previously, Brandon was Segment Lead for Generics, with product management responsibility for Newport, Clarivate’s active ingredient and generic dose manufacturing intelligence solution. Prior to joining Clarivate, Brandon held roles of increasing responsibility in pipeline portfolio management and market research in the generics division of Teva Pharmaceuticals.
Register below and we'll send the details straight to your inbox.
